DE60032784D1 - Markerproteine für prostatakrebs - Google Patents

Markerproteine für prostatakrebs

Info

Publication number
DE60032784D1
DE60032784D1 DE60032784T DE60032784T DE60032784D1 DE 60032784 D1 DE60032784 D1 DE 60032784D1 DE 60032784 T DE60032784 T DE 60032784T DE 60032784 T DE60032784 T DE 60032784T DE 60032784 D1 DE60032784 D1 DE 60032784D1
Authority
DE
Germany
Prior art keywords
prostate cancer
marker proteins
patients
subjects
prostate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE60032784T
Other languages
English (en)
Other versions
DE60032784T2 (de
Inventor
Tai-Tung Yip
Christine Yip
L Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eastern Virginia Medical School
Aspira Womens Health Inc
Original Assignee
Eastern Virginia Medical School
Ciphergen Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22568045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60032784(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Medical School, Ciphergen Biosystems Inc filed Critical Eastern Virginia Medical School
Application granted granted Critical
Publication of DE60032784D1 publication Critical patent/DE60032784D1/de
Publication of DE60032784T2 publication Critical patent/DE60032784T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE60032784T 1999-10-07 2000-10-06 Markerproteine für prostatakrebs Revoked DE60032784T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15842299P 1999-10-07 1999-10-07
US158422P 1999-10-07
PCT/US2000/027682 WO2001025791A2 (en) 1999-10-07 2000-10-06 Prostate cancer marker proteins

Publications (2)

Publication Number Publication Date
DE60032784D1 true DE60032784D1 (de) 2007-02-15
DE60032784T2 DE60032784T2 (de) 2007-11-08

Family

ID=22568045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032784T Revoked DE60032784T2 (de) 1999-10-07 2000-10-06 Markerproteine für prostatakrebs

Country Status (7)

Country Link
EP (1) EP1224466B1 (de)
JP (1) JP2004500553A (de)
AT (1) ATE350662T1 (de)
AU (1) AU7868300A (de)
CA (1) CA2386669A1 (de)
DE (1) DE60032784T2 (de)
WO (1) WO2001025791A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1269194B1 (de) * 2000-03-20 2007-03-07 Eastern Virginia Medical School Prostatakrebs-marker
AUPQ886100A0 (en) * 2000-07-19 2000-08-10 Biotron Limited Diagnostic test
GB2379737A (en) * 2001-09-05 2003-03-19 Univ Geneve Diagnostic method for spongiform encephalopathy disease
US20060088830A1 (en) * 2002-02-21 2006-04-27 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
AU2003274368B2 (en) 2002-10-30 2008-11-20 Proteome Sciences Plc. Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
AU2003296086A1 (en) 2002-12-26 2004-07-22 Nitto Boseki Co., Ltd. Immunoassay method and kit to be used therein
EP1895302A3 (de) 2003-04-08 2008-05-14 Colotech A/S Verfahren zum Nachweis von kolorektalem Krebs in menschlichen Proben
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP4568551B2 (ja) * 2004-07-28 2010-10-27 一晃 掛樋 糖たん白質糖鎖の分析方法及び非標識糖鎖の製造方法
EP1866648A2 (de) 2005-04-07 2007-12-19 mosaiques diagnostics and therapeutics AG Polypeptidmarker zur diagnose von prostatakrebs
WO2007109881A1 (en) * 2006-03-24 2007-10-04 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
GB0617429D0 (en) 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
EP2012127A3 (de) * 2007-07-03 2009-03-11 Koninklijke Philips Electronics N.V. Diagnosemarkierungen zur Erkennung von Prostatakrebs
US20140134658A1 (en) * 2010-05-21 2014-05-15 Notrhwestern University, An Illinois Not For Profit Corporation Psa enzymatic activity: a new biomarker for assessing prostate cancer aggressiveness
WO2011146143A2 (en) * 2010-05-21 2011-11-24 Ohmx Corporation Detection of cancer by assaying psa enzymatic activity
EP2707712A2 (de) 2011-05-13 2014-03-19 King's College London Verfahren und zusammensetzungen im zusammenhang mit thrombozytenempfindlichkeit
EP3047274A2 (de) * 2013-09-20 2016-07-27 Ohmx Corporation Psa-enzymaktivität: neuer biomarker zur bestimmung der aggressivität von prostatakrebs
EP4010456A4 (de) 2019-08-05 2023-09-13 Seer, Inc. Systeme und verfahren zur probenvorbereitung, datenerzeugung und proteinkoronaanalyse

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143864A (en) * 1994-06-28 2000-11-07 Merck & Co., Inc. Peptides
US5866679A (en) * 1994-06-28 1999-02-02 Merck & Co., Inc. Peptides
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
WO1998040738A1 (en) * 1997-03-11 1998-09-17 Sloan Kettering Institute For Cancer Research Prostate specific antigen substrates
US6207370B1 (en) * 1997-09-02 2001-03-27 Sequenom, Inc. Diagnostics based on mass spectrometric detection of translated target polypeptides
US6300088B1 (en) * 1997-11-24 2001-10-09 Duke University Method of detecting prostate specific antigen
EP1047793B1 (de) * 1998-01-21 2006-11-15 Dianon Systems, Inc. Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
AU4409099A (en) * 1998-05-29 1999-12-13 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
EP1224466B1 (de) 2007-01-03
WO2001025791A3 (en) 2001-12-27
WO2001025791A2 (en) 2001-04-12
ATE350662T1 (de) 2007-01-15
JP2004500553A (ja) 2004-01-08
DE60032784T2 (de) 2007-11-08
CA2386669A1 (en) 2001-04-12
EP1224466A2 (de) 2002-07-24
AU7868300A (en) 2001-05-10

Similar Documents

Publication Publication Date Title
ATE350662T1 (de) Markerproteine für prostatakrebs
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
DK0580596T3 (da) Gen muteret i colorektal cancer hos mennesker
ATE238557T1 (de) Krebsbehandlung
WO1997036535A3 (en) Biomarkers for detection, diagnosis and prognosis of prostate cancer
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
BR0316111A (pt) Métodos para diagnosticar rcc e outros tumores sólidos
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DE69933989D1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
AU9779498A (en) Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
DE60223176D1 (de) Metallkomplexverbindungen
DE60127104D1 (de) Prostatakrebs-marker
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
IL151448A0 (en) Proteins
ATE277352T1 (de) Einetenascin-c isoform als marker für neoplasmen
DE60221115D1 (de) Zusammensetzungen und verfahren zur verwendung von fibronektin-fragmenten bei krebsdiagnose
DE60119731D1 (de) Immunologisches test und satz zur diagnose von prostatadenokarzinom
DE69939623D1 (de) Polymorphe marker von prostatakarzinom tumorantigen-1 (pcta-1)
WO2003058198A3 (en) Human breast cancer biomarkers
ATE256682T1 (de) Sigma-2 rezeptoren als biomarkierer der tumorzellenproliferation
HUP0303899A2 (hu) SMARC-nukleinsavak és -polipeptidek prosztatarák diagnosztizálására és gyógykezelésére hasznos expressziós analízise
WO2003043566A3 (en) Hip1 cancer markers
GR1004636B (el) Προγνωσηατουακαρκινουαμεαχρησηατησαθυμοσινησαβ@α}τβ@bαα

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee
8331 Complete revocation